Marks and Spencer Group plc (LON:MKS – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The stock traded as high as GBX 376.60 ($5.04) and last traded at GBX 375.20 ($5.02), with a volume of 348779781 shares changing hands. The stock had previously closed at GBX 369.50 ($4.95).
Wall Street Analysts Forecast Growth
Several research firms recently commented on MKS. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Marks and Spencer Group in a research note on Friday, June 28th. Shore Capital reiterated a “house stock” rating on shares of Marks and Spencer Group in a research note on Thursday, May 30th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 350 ($4.69) target price on shares of Marks and Spencer Group in a research note on Friday, June 28th. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of GBX 322.50 ($4.32).
View Our Latest Analysis on Marks and Spencer Group
Marks and Spencer Group Price Performance
Insider Transactions at Marks and Spencer Group
In other news, insider Stuart Machin sold 619,188 shares of the stock in a transaction on Tuesday, July 2nd. The stock was sold at an average price of GBX 289 ($3.87), for a total value of £1,789,453.32 ($2,396,161.38). Company insiders own 0.88% of the company’s stock.
Marks and Spencer Group Company Profile
Marks and Spencer Group plc operates various retail stores. It operates through five segments: UK Clothing & Home, UK Food, International, Ocado, and All Other. The company offers protein deli and dairy; produce; ambient and in-store bakery; meals dessert and frozen; and hospitality and Food on the Move' products.
Read More
- Five stocks we like better than Marks and Spencer Group
- Stock Splits, Do They Really Impact Investors?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Invest in the Best Canadian Stocks
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 3 Tickers Leading a Meme Stock Revival
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Marks and Spencer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marks and Spencer Group and related companies with MarketBeat.com's FREE daily email newsletter.